DSpace Repository

The Role of Protein Kinase C in Mammalian Target of Rapamycin Signaling and its Therapeutic Implications in Non-Small Cell Lung Cancer

Show simple item record

dc.contributor.advisor Hannun, Yusuf en_US
dc.contributor.author Liu, Mengling en_US
dc.contributor.other Department of Molecular and Cellular Biology en_US
dc.date.accessioned 2017-09-20T16:50:21Z
dc.date.available 2017-09-20T16:50:21Z
dc.date.issued 2016-12-01 en_US
dc.identifier.uri http://hdl.handle.net/11401/76467 en_US
dc.description 135 pgs en_US
dc.description.abstract The mammalian target of rapamycin (mTOR) signaling pathway, which integrates extracellular and intracellular signals, plays a key role in cell metabolism, growth and survival; therefore, the proteins in the signaling pathway must be tightly regulated in order to maintain cellular homeostasis. Conversely, dysregulation of key components of mTOR signaling pathway leads to increased cellular growth and proliferation, which is implicated in many human cancers. Protein kinase C (PKC) is a family of serine/ threonine kinases that regulate many cellular processes including proliferation and cell survival. It has been shown to regulate mTOR signaling in some human cancers. However, the mechanism by which PKC regulates mTOR remains unclear. Recently, studies from our lab have shown that sustained activation of PKC induces robust phosphorylation of p70S6K, a well-known substrate of mTORC1, in a delayed pattern, and this phosphorylation requires classical PKC (cPKC) and phospholipase D (PLD). Importantly, the phosphorylation of p70S6K requires internalization of cPKC and the formation of the cPKC- containing endosomes, a dynamic subset of the slow recycling compartment that depends on PKC and PLD. In addition, we observed that sustained activation of PKC induces mTOR translocation to lysosomes, which appears to require the distinct nPKCs subfamily. Indeed, with PMA treatment, the mTOR- containing lysosomes become very close to the PLD-and PKC- containing endosomes but they remain distinct. These data suggest that sustained activation of PKC activates mTORC1 through a novel and more complicated mechanism. Lastly we found that a subset of non-small cell lung cancer (NSCLC) cell lines which have constitutively active epidermal growth factor receptor (EGFR) tends to have higher protein level of protein kinase c α (PKCα). Interestingly, in these cancer cells, the activation of mTOR is highly dependent on the activity of PKCα and PLD, and these cells utilize this pathway for cell survival. These data have important clinical implication as most NSCLC patients develop secondary mutation in EGFR and resistance to treatment with EGFR inhibitors, and our data provide evidence that targeting PKCα in mutant EGFR-mediated cancers may be used as second line treatment after patients develop the secondary mutation. en_US
dc.description.sponsorship This work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree. en_US
dc.format Monograph en_US
dc.format.medium Electronic Resource en_US
dc.language.iso en_US en_US
dc.publisher The Graduate School, Stony Brook University: Stony Brook, NY. en_US
dc.subject.lcsh Molecular biology en_US
dc.subject.other epidermal growth factor receptor, G protein-coupled receptor, mTORC1, Protein Kinase C en_US
dc.title The Role of Protein Kinase C in Mammalian Target of Rapamycin Signaling and its Therapeutic Implications in Non-Small Cell Lung Cancer en_US
dc.type Dissertation en_US
dc.mimetype Application/PDF en_US
dc.contributor.committeemember Frohman, Michael en_US
dc.contributor.committeemember Haley, John en_US
dc.contributor.committeemember Mao, Cungui en_US
dc.contributor.committeemember Luberto, Chiara en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account